October 16, 2020-Pfizer will not apply for an emergency license for the coronavirus vaccine until the third week of November, the company’s CEO said in a statement posted on Pfizer’s website on Friday.
The reversal of the company’s previous claim to apply for approval in October is a blow to US President Donald Trump, who repeatedly stated that the vaccine would be available before the November 3 election day. New York Times report.
Even if Pfizer had preliminary data on vaccine efficacy by the end of October, it would take at least the third week of November to collect safety and manufacturing data, Dr. Albert Bula said in a statement.
Pfizer’s announcement was welcomed by some scientists.
“This is good, really good,” said Dr. Eric Topol, a clinical trial expert at Scripps Research in San Diego. Times.. He was one of 60 public health officials and other medical professionals who sent a letter to Pfizer not to rush the vaccine. Times report.
Pfizer is one of four companies vaccinated with coronavirus vaccine in late-stage clinical trials in the United States. Others include Moderna, AstraZeneca, Johnson & Johnson. Pfizer showed the most optimistic timeline, but said the other three are likely later this year.